The Republican-controlled U.S. House of Representative Passes Major Bill 216 - 211 - Now Federal Employees File Complaint...

The Republican-controlled U.S. House of Representatives passed legislation on a near party-line vote of 216 to 211 that would criminalize gender transition medical procedures for minors, including surgeries and the provision of hormones or puberty blockers. The bill imposes penalties of up to ten years in federal prison for providers who perform or supply such treatments to individuals under 18.

The measure was forcefully advanced by Republican Representative Marjorie Taylor Greene of Georgia, who conditioned her support for an earlier defense policy bill on Speaker Mike Johnson bringing her legislation to the floor. Greene described the bill as fulfilling a key campaign pledge by President Donald Trump and stated that it formalizes an executive order aimed at banning gender-affirming medical interventions for minors. During floor debate, Greene displayed a poster of a child who had undergone such a procedure, arguing that “most Americans agree that kids just need to grow up before they do anything radical.”

The legislation is considered unlikely to advance in the Senate, where it would require bipartisan support to overcome procedural hurdles. Civil rights organizations have labeled the bill among the most extreme anti-transgender measures ever considered by Congress. The vote reflects the priorities of the ultraconservative Republican majority and the Trump administration’s focus on restricting gender-related healthcare for minors.

Separately, the Trump administration is confronting a formal legal complaint from federal employees affected by a new policy set to take effect Thursday. The Office of Personnel Management announced in August that federal employee and U.S. Postal Service health insurance plans will no longer cover “chemical and surgical modification of an individual’s sex traits through medical interventions.” The Human Rights Campaign filed the grievance with the Equal Employment Opportunity Commission on Thursday, asserting that the denial of coverage constitutes sex-based discrimination.

The complaint, submitted on behalf of four current federal workers at the State Department, Department of Health and Human Services, and Postal Service, includes statements from employees directly impacted. One Postal Service employee described a daughter diagnosed with gender dysphoria whose doctors have recommended puberty blockers and possible hormone replacement therapy, treatments that would no longer be covered. The filing asserts the claim on behalf of the employees and a proposed class of similarly situated federal workers.

Human Rights Campaign Foundation President Kelley Robinson stated that the policy “is not about cost or care—it is about driving transgender people and people with transgender spouses, children, and dependents out of the federal workforce.”

The grievance comes amid broader Trump administration efforts to limit access to gender-transition care, particularly for minors. In December, the Department of Health and Human Services proposed rules that would prohibit such care for minors and deny Medicare and Medicaid funding to hospitals and providers offering these services to children. High-ranking officials, including HHS Secretary Robert F. Kennedy Jr., have described gender-affirming care for minors as “malpractice.” These positions stand in contrast to the recommendations of major medical organizations such as the American Medical Association and the American Academy of Pediatrics.

The developments illustrate ongoing tensions between the Trump administration’s policy objectives and advocacy groups seeking to preserve access to gender-related healthcare. While the House bill advances one element of the president’s agenda through legislative action, the OPM policy change represents an executive-branch initiative already facing legal challenge. The complaint seeks revocation of the coverage exclusion, setting the stage for potential administrative or judicial review.

Rep. Greene, who played a pivotal role in securing the House vote, announced last month that she would leave Congress one year before the end of her term. Her departure adds another layer of transition within the Republican conference as it pursues its legislative priorities.